Pediatric Off-label Antipsychotic Use for Attention-Deficit/Hyperactivity Disorder

Off-label antipsychotic use for behavioral symptoms in pediatric attention-deficit/hyperactivity disorder (ADHD) poses safety concerns, and evidence to support such use is limited. This study aims to investigate the risk of off-label antipsychotic use associated with comorbid disruptive behavior dis...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical therapeutics 2022-09, Vol.44 (9), p.e83-e90
Hauptverfasser:	Lee, Haeyoung, Zhang, Chengchen, Rose, Roderick, dosReis, Susan
Format:	Artikel
Sprache:	eng
Schlagworte:	ADHD Adjustment Age Antipsychotics Anxiety disorders Attention deficit hyperactivity disorder Autism Behavior disorders Bipolar disorder Children & youth Comorbidity Conduct disorder Criteria Diagnosis Disruptive behavior disorder Emotional disorders FDA approval Hyperactivity Mental disorders Mood disorders Off-label Pediatrics Pharmacy Psychosis Psychotropic drugs Schizophrenia Statistical significance Tourette syndrome Youth
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!